Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.
Chemistry, toxicology, pharmacology and pharmacokinetics of idebenone: a review.
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Cost-effectiveness analysis of interferon beta-1b as treatment for patients with clinically isolated syndrome suggestive of multiple sclerosis in Spain.
Restoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Mitoxantrone for multiple sclerosis.
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α
HL-A antigens and multiple sclerosis.
Subcutaneous IFN-β1a to treat relapsing-remitting multiple sclerosis.
Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Optimizing IFN Beta - 1B Dose (Optims)
Study hints of rituximab MS benefit
Reactive astrocytes as therapeutic targets for CNS disorders.
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.
Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
Integrated analysis of daclizumab HYP pharmacokinetics from three phase 1 studies

Pages